ResMed (RMD) Competitors $225.47 -11.16 (-4.72%) Closing price 03:59 PM EasternExtended Trading$219.98 -5.49 (-2.43%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RMD vs. BSX, MDT, BDX, EW, IDXX, DXCM, STE, BAX, PODD, and HOLXShould you be buying ResMed stock or one of its competitors? The main competitors of ResMed include Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Baxter International (BAX), Insulet (PODD), and Hologic (HOLX). These companies are all part of the "health care equipment" industry. ResMed vs. Boston Scientific Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories DexCom STERIS Baxter International Insulet Hologic Boston Scientific (NYSE:BSX) and ResMed (NYSE:RMD) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Does the MarketBeat Community prefer BSX or RMD? Boston Scientific received 626 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 69.70% of users gave Boston Scientific an outperform vote while only 52.63% of users gave ResMed an outperform vote. CompanyUnderperformOutperformBoston ScientificOutperform Votes105669.70% Underperform Votes45930.30% ResMedOutperform Votes43052.63% Underperform Votes38747.37% Is BSX or RMD more profitable? ResMed has a net margin of 25.34% compared to Boston Scientific's net margin of 11.07%. ResMed's return on equity of 26.17% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Boston Scientific11.07% 17.80% 9.85% ResMed 25.34%26.17%18.60% Which has more risk & volatility, BSX or RMD? Boston Scientific has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, ResMed has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Does the media refer more to BSX or RMD? In the previous week, ResMed had 2 more articles in the media than Boston Scientific. MarketBeat recorded 39 mentions for ResMed and 37 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.07 beat ResMed's score of 0.87 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 27 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive ResMed 22 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of BSX or RMD? 89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 55.0% of ResMed shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 0.7% of ResMed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer BSX or RMD? Boston Scientific currently has a consensus price target of $108.91, indicating a potential upside of 14.33%. ResMed has a consensus price target of $243.82, indicating a potential upside of 6.49%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than ResMed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 0 Sell rating(s) 1 Hold rating(s) 21 Buy rating(s) 1 Strong Buy rating(s) 3.00ResMed 1 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.67 Which has higher earnings and valuation, BSX or RMD? Boston Scientific has higher revenue and earnings than ResMed. ResMed is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBoston Scientific$16.75B8.39$1.85B$1.2576.21ResMed$4.93B6.83$1.02B$8.4727.03 SummaryBoston Scientific beats ResMed on 12 of the 19 factors compared between the two stocks. Remove Ads Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMD vs. The Competition Export to ExcelMetricResMedSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$33.11B$4.29B$5.67B$19.15BDividend Yield0.95%39.84%4.89%3.79%P/E Ratio26.6228.0924.8332.66Price / Sales6.7248.42382.6026.97Price / Cash25.2351.0838.0517.55Price / Book6.306.036.854.53Net Income$1.02B$67.09M$3.19B$1.02B7 Day Performance-2.53%1.35%-0.50%-1.46%1 Month Performance-5.05%-8.76%-6.63%-6.18%1 Year Performance18.77%16.41%8.73%3.91% ResMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMDResMed4.0203 of 5 stars$225.47-4.7%$243.82+8.1%+26.0%$33.11B$4.93B26.629,980Insider TradeNews CoverageBSXBoston Scientific4.5465 of 5 stars$93.47-5.7%$108.91+16.5%+38.6%$138.00B$16.75B74.8145,000Analyst DowngradePositive NewsHigh Trading VolumeMDTMedtronic4.5517 of 5 stars$93.85-0.7%$96.07+2.4%+10.1%$120.44B$33.20B28.5495,000Dividend AnnouncementPositive NewsBDXBecton, Dickinson and Company4.7395 of 5 stars$228.79+0.1%$278.29+21.6%-5.3%$65.64B$20.64B37.9774,000Positive NewsEWEdwards Lifesciences4.6691 of 5 stars$68.37-2.8%$79.95+16.9%-25.7%$40.22B$5.44B9.8117,300Insider TradeIDXXIDEXX Laboratories4.4688 of 5 stars$435.95+1.4%$533.75+22.4%-22.3%$35.45B$3.90B40.8510,800Positive NewsDXCMDexCom4.9081 of 5 stars$71.50-8.1%$99.82+39.6%-47.7%$28.07B$4.03B50.247,600Analyst ForecastSTESTERIS4.6535 of 5 stars$230.68-0.9%$258.75+12.2%-0.9%$22.67B$5.40B48.9818,179Positive NewsBAXBaxter International4.4384 of 5 stars$36.53-0.1%$38.56+5.5%-16.3%$18.70B$10.64B-28.5660,000Analyst ForecastPODDInsulet4.7263 of 5 stars$233.54-7.3%$292.06+25.1%+32.0%$16.40B$2.07B40.343,000HOLXHologic4.8333 of 5 stars$65.67+1.8%$84.62+28.8%-14.8%$14.73B$4.04B20.707,063 Remove Ads Related Companies and Tools Related Companies Boston Scientific Competitors Medtronic Competitors Becton, Dickinson and Company Competitors Edwards Lifesciences Competitors IDEXX Laboratories Competitors DexCom Competitors STERIS Competitors Baxter International Competitors Insulet Competitors Hologic Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:RMD) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RMD Stock Alerts